Poster published at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting shows the final 5 year safety data from the Phase IIb breast cancer clinical trial. Final safety conclusions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback